next generation chimeric decoy-oligonucleotide (AnGes)

N/A

Report date: 2025/03/20 15:11:41
NME

Base Information

Drug Namenext generation chimeric decoy-oligonucleotide (AnGes)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTumor necrosis factor ligand superfamily member 11 inhibitorsSignal transducer and activator of transcription 6 inhibitors
TargetsSignal transducer and activator of transcription 6Tumor necrosis factor ligand superfamily member 11
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAnges Inc
China Registration ClassN/A

Develop Information

Active CompaniesAnges Inc
Inactive CompaniesN/A
Active IndicationsInflammation
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A